Hypothalamic digoxin, hemispheric chemical dominance, and chronic bronchitis emphysema

Area of Science:

• Biochemistry
• Pulmonology
• Neuroscience

Background:

• The isoprenoid pathway yields critical metabolites: endogenous digoxin, dolichol, and ubiquinone.
• Chronic bronchitis emphysema (CBE) involves complex biochemical and potentially neurological factors.
• Hemispheric dominance is increasingly recognized for its influence on physiological processes.

Purpose of the Study:

• To investigate the isoprenoid pathway's role in chronic bronchitis emphysema pathogenesis.
• To explore the association between hemispheric dominance and CBE.
• To identify biochemical markers and their correlation with brain function in CBE patients.

Main Methods:

• Assessed isoprenoid pathway metabolites in CBE patients.
• Utilized the dichotic listening test to determine hemispheric dominance.
• Analyzed biochemical markers including digoxin, dolichol, ubiquinone, free radicals, and glycoconjugates.
• Correlated biochemical findings with hemispheric dominance patterns.

Main Results:

• CBE patients exhibited elevated endogenous digoxin and dolichol, decreased ubiquinone, and increased free radicals.
• All CBE patients displayed left-hemispheric dominance.
• Biochemical profiles in CBE mirrored those in individuals with right hemispheric dominance.
• Increased free radicals and altered glycoconjugate metabolism contribute to immune activation and disease pathology.

Conclusions:

• Altered isoprenoid pathway and left-hemispheric dominance are implicated in chronic bronchitis emphysema.
• Endogenous digoxin and free radical generation may drive immune activation in CBE.
• Biochemical changes in CBE suggest a link to altered brain function and hemispheric dominance.